Economic Times
Business Standard
Ø IMF slashes Asia's growth forecast
Ø UNCTAD sees 7-9% dip in 2020 global trade
Ø India at the cusp of economic recovery: RBI Governor
Ø Cabinet to soon consider new PSE policy: DEA Secretary
Ø Government pushes strategic PSU sales, 4 companies may net Rs 49,000 crore
Ø World trade rebounds slowly in Sept quarter, outlook uncertain
Ø Purdue Pharma to plead guilty and pay $8.3 billion over opioids
Ø India receives highest ever FDI in Apr-Aug FY21: Government
Ø MFs, alternative investment funds may come under ambit of new tax norms
Ø Govt open to further stimulus to lift economy, says DEA Secretary
Ø Hindustan Copper board to consider raising funds by issue of shares via QIP
Ø RBI to release on-tap TLTRO funds every Monday, scheme to run till Mar 31
Ø Modi to meet 15 global funds as India seeks investment to lift economy
Ø Fin sector must reduce reliance on banking system for fundraise: Sebi chief
Ø Canada's annual inflation rate accelerates to 0.5% in September
Business Line
Mint
Ø Aatmanirbhar Bharat: Raghuram Rajan cautions against import substitution by erecting tariffs
Ø USAID announces $5 m to support India’s initiatives
Ø India opposes US, Brazil push for fast implementation of trade facilitation measures at WTO
Ø India posted strong mid single-digit growth: Nestle
Ø UltraTech Q2 net more than doubles to ₹1,235 cr
Ø JK Tyre Q2 net down 34% at ₹110 crore
Ø Sebi penalises Kirloskar brothers on charges of fraud
Ø Bajaj Finance Q2 net profit drops 36% on higher provisioning
Ø Equitas Small Finance Bank IPO subscribed 67 pc on second day of bidding
Ø Brexit talks set to restart with aim of deal by mid-November
Ø ReNew Power’s $325 million dollar bond offering sees strong demand
Financial Express
Deccan Chroicle
Ø Commerce ministry recommends continuation of anti-dumping duty on Chinese Synthetic Rubber
Ø Neutralising negative growth, Coal India poised for output ramp-up
Ø E-tailing to become USD 200-billion opportunity by 2025: Report
Ø India receives $35 billion FDI in first five months of the fiscal
Ø Pharma sector may post Covid-induced rise in Q2 earnings
By: via @AlliesFin Serve Stock Market
